Evidence map›Paper›PMID 32095915›Full record

ArticlePsychopharmacology2020

Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.

Aldemara I Silva, Victor A D Holanda, Joaquim G Azevedo Neto, Edilson D Silva Junior, Vanessa P Soares-Rachetti, Girolamo Calo, Chiara Ruzza, Elaine C Gavioli

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Anxiety and Depression: What Do We Know of Neuropeptides?Behavioral sciences (Basel, Switzerland) · 2022
    Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Aldemara I SilvaDepartment of Biophysics and Pharmacology, Federal University of Rio Grande do Norte, Av. Sen. Salgado Filho, 3000, Lagoa Nova, Natal, 59078-970, Brazil.
Victor A D HolandaDepartment of Biophysics and Pharmacology, Federal University of Rio Grande do Norte, Av. Sen. Salgado Filho, 3000, Lagoa Nova, Natal, 59078-970, Brazil.
Joaquim G Azevedo NetoDepartment of Biophysics and Pharmacology, Federal University of Rio Grande do Norte, Av. Sen. Salgado Filho, 3000, Lagoa Nova, Natal, 59078-970, Brazil.
Edilson D Silva JuniorDepartment of Biophysics and Pharmacology, Federal University of Rio Grande do Norte, Av. Sen. Salgado Filho, 3000, Lagoa Nova, Natal, 59078-970, Brazil.
Vanessa P Soares-RachettiDepartment of Biophysics and Pharmacology, Federal University of Rio Grande do Norte, Av. Sen. Salgado Filho, 3000, Lagoa Nova, Natal, 59078-970, Brazil.
Girolamo CaloDepartment of Medical Sciences, Section of Pharmacology, and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Chiara RuzzaDepartment of Medical Sciences, Section of Pharmacology, and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Elaine C GavioliDepartment of Biophysics and Pharmacology, Federal University of Rio Grande do Norte, Av. Sen. Salgado Filho, 3000, Lagoa Nova, Natal, 59078-970, Brazil. egavioli@hotmail.com.ORCID http://orcid.org/0000-0001-8967-1369
Universidade Federal do Rio Grande do Norte · BRUniversity of Ferrara · IT

Funding

Brazilian National Council Research 302302/2015-8Brazilian National Council Research 401837/2016-5Brazilian National Research Council PDJ fellowshipCAPES Foudating MSc scholarship
6 · The paper itself

Abstract

rationaleDepression and anxiety frequently co-occur, and this has important clinical implications. Previous studies showed that activation of the nociceptin/orphanin FQ receptor (NOP) elicits anxiolytic effects, while its blockade promotes consistent antidepressant actions. NOP antagonists are effective in reversing footshock-induced depressive-like behaviors, but their effects on stress-induced anxiety are still unclear.

objectiveThis study aimed to investigate the effects of the NOP antagonist SB-612111 on footshock stress-induced anxiety behaviors.

methodsMale Swiss mice were exposed to inescapable electric footshock stress, and behavioral phenotype was screened based on the ability to escape from footshock (i.e., helpless or non-helpless). Animals were then treated with diazepam (1 mg/kg) and SB-612111 (0.1-10 mg/kg), and their behavior was assessed in the elevated plus-maze (EPM) and open field test.

resultsWhen compared with non-stressed mice, helpless, but not non-helpless, animals displayed significant reductions in the time spent in and entries into open arms in the EPM. Diazepam significantly increased open arms exploration in helpless, non-helpless, and non-stressed mice. However, treatment with the NOP antagonist SB-612111 was inactive in naive mice, while it reversed anxiogenic-related behaviors in helpless mice and increased anxiety states in non-helpless mice. No effects on locomotion were observed.

conclusionHelpless mice displayed increased anxiety compared to non-stressed and non-helpless animals, thus supporting use of this approach as an animal model to investigate anxiety/depression comorbidity. Additionally, SB-612111 modulated anxiety-like behaviors in male mice depending on individual stress susceptibility. Ultimately, NOP antagonists could be useful for treating anxiety in depressed patients.

Indexed as

AnimalsAnti-Anxiety AgentsAntidepressive AgentsAnxietyCycloheptanesDepressionEmotionsMaleMiceNociceptin ReceptorPiperidinesReceptors, OpioidStress, PsychologicalAnti-Anxiety AgentsAntidepressive Agentscis-1-methyl-7-((4-(2,6-dichlorophenyl)piperidin-1-yl)methyl)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-olCycloheptanesNociceptin ReceptorOprl1 protein, mousePiperidinesReceptors, OpioidAnxietyDepressionHelpless behaviorInescapable stressNociceptin/orphanin FQNOP antagonist

Identifiers

PMID32095915
OpenAlexW3008671207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.